In Vitro and In Vivo Activity of Luliconazole (NND-502) against Planktonic Cells and Biofilms of Azole Resistant <i>Aspergillus fumigatus</i>

<i>Aspergillus fumigatus</i> has become a significant threat in clinical settings. Cases of invasive infections with azole-resistant <i>A. fumigatus</i> isolates (ARAF) increased recently. Developing strategies for dealing with ARAF has become crucial. We here investigated th...

Full description

Bibliographic Details
Main Authors: Dan-Tiberiu Furnica, Silke Dittmer, Maike Isabell Sanders, Joerg Steinmann, Peter-Michael Rath, Lisa Kirchhoff
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Journal of Fungi
Subjects:
Online Access:https://www.mdpi.com/2309-608X/8/4/350
_version_ 1797445531595702272
author Dan-Tiberiu Furnica
Silke Dittmer
Maike Isabell Sanders
Joerg Steinmann
Peter-Michael Rath
Lisa Kirchhoff
author_facet Dan-Tiberiu Furnica
Silke Dittmer
Maike Isabell Sanders
Joerg Steinmann
Peter-Michael Rath
Lisa Kirchhoff
author_sort Dan-Tiberiu Furnica
collection DOAJ
description <i>Aspergillus fumigatus</i> has become a significant threat in clinical settings. Cases of invasive infections with azole-resistant <i>A. fumigatus</i> isolates (ARAF) increased recently. Developing strategies for dealing with ARAF has become crucial. We here investigated the in-vitro and in-vivo activity of the imidazole luliconazole (LLCZ) against clinical ARAF. In total, the LLCZ minimum inhibitory concentrations (MICs) were tested for 101 <i>A. fumigatus</i> isolates (84 ARAF and 17 azole-susceptible <i>A. fumigatus</i> as wild-type controls) according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST). Additionally, antifungal activity was assessed in vitro, including an XTT planktonic growth kinetics assay and biofilm assays (crystal violet and XTT assay). Further, a single-dose LLCZ treatment (152 mg/L) was tested for seven days in vivo in a <i>Galleria mellonella</i> infection model. LLCZ showed an MIC<sub>50</sub> of 0.002 mg/L and no significant difference was found between triazole-resistant and wild-type isolates. Growth inhibition took place between 6 and 12 h after the start of incubation. LLCZ inhibited biofilm formation when added in the pre-adhesion stages. In vivo, single-dose LLCZ-treated larvae show a significantly higher survival percentage than the control group (20%). In conclusion, LLCZ has activity against planktonic cells and early biofilms of ARAF.
first_indexed 2024-03-09T13:27:09Z
format Article
id doaj.art-4a802a52a62646deb49dd9d846a5c90d
institution Directory Open Access Journal
issn 2309-608X
language English
last_indexed 2024-03-09T13:27:09Z
publishDate 2022-03-01
publisher MDPI AG
record_format Article
series Journal of Fungi
spelling doaj.art-4a802a52a62646deb49dd9d846a5c90d2023-11-30T21:21:52ZengMDPI AGJournal of Fungi2309-608X2022-03-018435010.3390/jof8040350In Vitro and In Vivo Activity of Luliconazole (NND-502) against Planktonic Cells and Biofilms of Azole Resistant <i>Aspergillus fumigatus</i>Dan-Tiberiu Furnica0Silke Dittmer1Maike Isabell Sanders2Joerg Steinmann3Peter-Michael Rath4Lisa Kirchhoff5Institute of Medical Microbiology, University Hospital Essen, University of Duisburg-Essen, 45122 Essen, GermanyInstitute of Medical Microbiology, University Hospital Essen, University of Duisburg-Essen, 45122 Essen, GermanyInstitute of Medical Microbiology, University Hospital Essen, University of Duisburg-Essen, 45122 Essen, GermanyInstitute of Medical Microbiology, University Hospital Essen, University of Duisburg-Essen, 45122 Essen, GermanyInstitute of Medical Microbiology, University Hospital Essen, University of Duisburg-Essen, 45122 Essen, GermanyInstitute of Medical Microbiology, University Hospital Essen, University of Duisburg-Essen, 45122 Essen, Germany<i>Aspergillus fumigatus</i> has become a significant threat in clinical settings. Cases of invasive infections with azole-resistant <i>A. fumigatus</i> isolates (ARAF) increased recently. Developing strategies for dealing with ARAF has become crucial. We here investigated the in-vitro and in-vivo activity of the imidazole luliconazole (LLCZ) against clinical ARAF. In total, the LLCZ minimum inhibitory concentrations (MICs) were tested for 101 <i>A. fumigatus</i> isolates (84 ARAF and 17 azole-susceptible <i>A. fumigatus</i> as wild-type controls) according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST). Additionally, antifungal activity was assessed in vitro, including an XTT planktonic growth kinetics assay and biofilm assays (crystal violet and XTT assay). Further, a single-dose LLCZ treatment (152 mg/L) was tested for seven days in vivo in a <i>Galleria mellonella</i> infection model. LLCZ showed an MIC<sub>50</sub> of 0.002 mg/L and no significant difference was found between triazole-resistant and wild-type isolates. Growth inhibition took place between 6 and 12 h after the start of incubation. LLCZ inhibited biofilm formation when added in the pre-adhesion stages. In vivo, single-dose LLCZ-treated larvae show a significantly higher survival percentage than the control group (20%). In conclusion, LLCZ has activity against planktonic cells and early biofilms of ARAF.https://www.mdpi.com/2309-608X/8/4/350ARAFluliconazolebiofilm<i>Galleria mellonella</i>
spellingShingle Dan-Tiberiu Furnica
Silke Dittmer
Maike Isabell Sanders
Joerg Steinmann
Peter-Michael Rath
Lisa Kirchhoff
In Vitro and In Vivo Activity of Luliconazole (NND-502) against Planktonic Cells and Biofilms of Azole Resistant <i>Aspergillus fumigatus</i>
Journal of Fungi
ARAF
luliconazole
biofilm
<i>Galleria mellonella</i>
title In Vitro and In Vivo Activity of Luliconazole (NND-502) against Planktonic Cells and Biofilms of Azole Resistant <i>Aspergillus fumigatus</i>
title_full In Vitro and In Vivo Activity of Luliconazole (NND-502) against Planktonic Cells and Biofilms of Azole Resistant <i>Aspergillus fumigatus</i>
title_fullStr In Vitro and In Vivo Activity of Luliconazole (NND-502) against Planktonic Cells and Biofilms of Azole Resistant <i>Aspergillus fumigatus</i>
title_full_unstemmed In Vitro and In Vivo Activity of Luliconazole (NND-502) against Planktonic Cells and Biofilms of Azole Resistant <i>Aspergillus fumigatus</i>
title_short In Vitro and In Vivo Activity of Luliconazole (NND-502) against Planktonic Cells and Biofilms of Azole Resistant <i>Aspergillus fumigatus</i>
title_sort in vitro and in vivo activity of luliconazole nnd 502 against planktonic cells and biofilms of azole resistant i aspergillus fumigatus i
topic ARAF
luliconazole
biofilm
<i>Galleria mellonella</i>
url https://www.mdpi.com/2309-608X/8/4/350
work_keys_str_mv AT dantiberiufurnica invitroandinvivoactivityofluliconazolennd502againstplanktoniccellsandbiofilmsofazoleresistantiaspergillusfumigatusi
AT silkedittmer invitroandinvivoactivityofluliconazolennd502againstplanktoniccellsandbiofilmsofazoleresistantiaspergillusfumigatusi
AT maikeisabellsanders invitroandinvivoactivityofluliconazolennd502againstplanktoniccellsandbiofilmsofazoleresistantiaspergillusfumigatusi
AT joergsteinmann invitroandinvivoactivityofluliconazolennd502againstplanktoniccellsandbiofilmsofazoleresistantiaspergillusfumigatusi
AT petermichaelrath invitroandinvivoactivityofluliconazolennd502againstplanktoniccellsandbiofilmsofazoleresistantiaspergillusfumigatusi
AT lisakirchhoff invitroandinvivoactivityofluliconazolennd502againstplanktoniccellsandbiofilmsofazoleresistantiaspergillusfumigatusi